Skip to main content
. Author manuscript; available in PMC: 2021 Jun 8.
Published in final edited form as: Leukemia. 2020 Sep 1;35(6):1643–1660. doi: 10.1038/s41375-020-01020-4

Figure 3: Response to non-pegylated IFN (IFN) and pegylated IFN (peg-IFN) in PV.

Figure 3:

A: Overall response rate (ORR)

B: Complete hematologic response (CHR) rate

C: Partial hematologic response (PHR) rate